Michael J. Demeure, M.D., F.A.C.S, F.A.C.E.

Program Director, Hoag Precision Medicine Program

  • Endocrine Surgeon
  • American Surgical Association Fellow
Phone 949-722-6237 Fax

Michael Demeure, M.D., is the Program Director for Precision Medicine at Hoag Family Cancer Institute, a fellowship-trained endocrine surgeon and elected Fellow of the American Surgical Association. His clinical focus is on tumors of the thyroid, parathyroid, adrenal glands and pancreas. Dr. Demeure is an internationally recognized expert in cancer surgery and research, with particular expertise in endocrine, pancreatic and gastrointestinal cancers.

Dr. Demeure has led an active research lab for over 20 years with the majority of his efforts centered on using genomic technologies to develop novel biomarkers, new therapeutic targets, and related therapies in the management of endocrine and gastrointestinal cancers, serving as a co- or principle investigator on some of the landmark trials in these areas. Over the past three years, Dr. Demeure helped the Translational Genomics Research Institute (TGen) with the launch and direction of Ashion, a commercial clinical sequencing lab, serving as the chief medical officer, executive vice-president and general manager.

Dr. Demeure is a past-President of the American Association of Endocrine Surgeons, is regularly recognized as one of “America’s Top Surgeons” and has been consecutively named as one of the “Best Doctors in America.” He is the author or co-author of over 100 scholarly works and has given over 150 invited lectures and presentations.